What is Interline Therapeutics?
Interline Therapeutics, based in San Francisco, CA, is a drug discovery company dedicated to systematically elucidating protein communities. Their core focus lies in defining the molecular mechanisms underlying various diseases. By employing advanced research methodologies, Interline Therapeutics aims to identify novel therapeutic targets and develop innovative treatments. The company's strategic approach to understanding complex biological systems positions it as a key player in the pharmaceutical research and development sector.
How much funding has Interline Therapeutics raised?
Interline Therapeutics has raised a total of $92M across 1 funding round:
Other Financing Round
$92M
Other Financing Round (2021): $92M with participation from ARCH Venture Partners and Foresite Capital
Key Investors in Interline Therapeutics
ARCH Venture Partners
ARCH Venture Partners is a leading earlystage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
Foresite Capital
Foresite Capital is a multi-stage investment firm focused on transforming healthcare and life sciences by investing in companies that utilize biology and big data. The firm targets breakthrough opportunities at the intersection of technology and biotechnology, employing a data science-driven investment approach.
What's next for Interline Therapeutics?
With the recent infusion of major strategic capital, Interline Therapeutics is poised for accelerated growth and enhanced research capabilities. This significant investment will likely fuel the expansion of its drug discovery platforms and support the progression of its lead programs through preclinical and clinical development. The company's focus on protein communities suggests a long-term strategy to tackle challenging diseases, and this funding provides the necessary resources to pursue these ambitious goals. Future developments may include strategic partnerships and the advancement of a robust pipeline of potential therapeutics.
See full Interline Therapeutics company page
